This finding suggests that for patients with MFS, if an FBN1 frameshift mutation or nonsense mutation is detected, we should provide more intense surveillance with a stricter imaging protocol and a low threshold for surgery. The gene discussed is FBN1; the disease is Marfan syndrome.